ZEISS Unveils Ultra-Widefield Fundus Imaging Technology in US

Register to receive a free US Market Report Suite for Diagnostic Ophthalmic Devices 2017 – MedSuite report synopsis and brochure

ZEISS CLARUS™ 500 Ultra-widefield system leverages legendary ZEISS precision optics to provide high resolution retinal imaging across the entire retina. CLARUS 500 is the first fundus imaging system combining true color and exceptional clarity within an ultra-wide field of view.

ZEISS Medical Technology recently announced the U.S. launch of its next generation, high-definition Ultra-widefield (HD UWF) fundus imaging system, CLARUS 500, at the International Vision Expo & Conference in Las Vegas, Nevada.

Leveraging ZEISS precision optics, CLARUS 500 is the first fundus camera that combines true color with high-resolution clarity down to 7 microns in an Ultra-widefield view from the macula to the far periphery. Early signs of eye disease can often be subtle and can occur in the far periphery of the retina. Now with ZEISS CLARUS 500 Ultra-widefield system, practitioners can obtain a better view of the entire fundus. CLARUS 500 produces exceptional images in True Color that closely resemble the coloration of the retina as seen through direct observation during clinical examination.

Color accuracy is important in the diagnosis, documentation and management of ocular diseases; ensuring confidence when evaluating optic disc, nevi, and lesions in which subtle color differences may lead to a change in diagnosis and management. Specifically, accurate coloration and resolution is important for evaluating focal change in rim tissue, nerve pallor, dry age-related macular degeneration RPE pigment changes, and drusen.

According to retinal specialist, Roger Goldberg MD, MBA with Bay Area Retina Associates, CLARUS 500 from ZEISS combines the benefits of an ultra-widefield view across the entire retina with the high-quality of traditional fundus photography used for imaging the optic nerve and macula. “By offering true-color, high-resolution images of the optic nerve and macula, as well as the retinal periphery, we no longer have to choose which system to image a patient on based on their retinal pathology,” Dr. Goldberg added.

“Traditional fundus imaging systems have been the gold standard for macular disease diagnosis and optic nerve evaluation for many years,” says Jim Mazzo, Global President Ophthalmic Devices at Carl Zeiss Meditec. “Now, Ultra-widefield is starting to change this. Clinicians are finding that by imaging a larger area of the retina, they have the possibility of uncovering more pathology, aiding in earlier disease diagnosis and better patient management. With ZEISS CLARUS, they can better manage a broader range of patients with one fundus imaging system,” Mazzo continues.

With a single capture, ZEISS CLARUS 500 produces a 133-degree HD widefield image. HD widefield images are automatically merged to achieve a 200-degree ultra-wide field of view. The technology allows clinicians to easily review and compare high-quality images captured during a single exam while providing annotation and caliper measurement tools that allow in-depth analysis of eye health. CLARUS integrates with ZEISS FORUM® and Retina Workplace for review with other ophthalmic images and exam data for efficient multi-modality analysis.

Another advantage of the CLARUS 500 is its ability for peripheral imaging while still maintaining the ability to zoom into the retina without losing resolution. Reticula degeneration in the periphery is a risk factor for AMD progression.

“ZEISS continually strives to evolve our legendary precision optics technology to help doctors advance patient care,” said Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec. “We are pleased to be able to add advanced Ultra-widefield imaging to the comprehensive portfolio of diagnostic imaging solutions that help doctors more easily detect eye disease and help preserve their patient’s vision.”

ZEISS CLARUS 500 Ultra-widefield is available in the United States beginning in September 2017. Availability is pending in all other major markets.

For more information about ZEISS CLARUS 500, visit www.zeiss.com/us/clarus

For Further Information
More on the diagnostic ophthalmic market in the U.S can be found in a series of reports published by iData Research entitled the U.S. Market Report Suite for Diagnostic Ophthalmic Devices. The suite covers reports on the following markets: Ophthalmic coherence tomography, fundus cameras, data management systems, slit lamps, perimeters, tonometers, autorefractors/keratometers, binocular indirect ophthalmoscopes, ophthalmic ultrasound devices, wavefront abberometers, corneal topographers and optical biometers.

The iData report series on ophthalmic devices covers the U.S. and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about ophthalmic device market data, register online or email us at info@idataresearch.net for a U.S. Market Report Suite for Diagnostic Ophthalmic Devices brochure and synopsis.

Leave a Reply